Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Adenoid Cystic × Epirubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 125 Stomach Neoplasms 20 Triple Negative Breast Neoplasms 17 Inflammatory Breast Neoplasms 12 Carcinoma, Hepatocellular 12 Esophageal Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 6 Pancreatic Neoplasms 4 Neoplasms 4 Urinary Bladder Neoplasms 3 Testicular Neoplasms 3 Sarcoma 3 Primary Breast Cancer 3 Gallbladder Neoplasms 3 Carcinoma, Ductal, Breast 3 Adenocarcinoma Of Esophagus 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasms, Germ Cell and Embryonal 2 Liver Neoplasms 2 Breast Neoplasms, Male 2 Breast Diseases 2 Women With Primary Breast Cancer 1 Wilms Tumor 1 Upper Tract Urothelial Carcinoma 1 Thymoma 1 Testicular Germ Cell Tumor 1

Interventions

pembrolizumab 3 lenvatinib 2 gallium 68 PSMA-11 2 apatinib 2 Magnetic Resonance Spectroscopy 2 Imatinib Mesylate 2 Cisplatin 2 Carboplatin 2 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2 tislelizumab 1 regorafenib 1 enfortumab vedotin 1 cabozantinib 1 amivantamab 1 Tretinoin 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiation 1 Protons 1 Pemetrexed 1 Nivolumab 1 Nelfinavir 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Lutetium-177 1 Lutetium 1 Glutamate Carboxypeptidase II 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07320508 2026-01-21

EIC-SNACC

Eye & ENT Hospital of Fudan University

Phase 2 Recruiting

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡